Ultrasound to check lymph nodes after head and neck cancer treatment
Part of Cancer clinical trials.
This trial uses contrast-enhanced ultrasound (a special type of ultrasound) to see how well neck lymph nodes respond to chemotherapy and immunotherapy given before surgery for head and neck squamous cell carcinoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of head and neck squamous cell carcinoma
- You received chemotherapy combined with immunotherapy before surgery
- CT or MRI scans before treatment showed cancer in your neck lymph nodes
- You had radical surgery at this hospital that included removal of neck lymph nodes
- You completed the full course of pre-surgery therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new surgical method to rebuild the lymph system in your neck during surgery for head and neck cancer. It aims to reduce swelling and improve recovery after removing lymph nodes as part of cancer treatment.
This early-stage study tests two different imaging (scanning) methods to better detect head and neck cancer. Your results from the scans may help doctors see where disease is before standard surgery to remove lymph nodes in the neck.
This Phase 1 study tests a labelling of panitumumab with iodine (111In) to see how well it can identify lymph nodes in head and neck cancer before surgery. The goal is to improve lymph node staging (which can help guide treatment), with the main focus on safety and early performance.
This trial tests giving a combination of two drugs (an immunotherapy drug called a PD-1 inhibitor and a targeted therapy called cetuximab) before surgery to shrink head and neck cancers. The goal is to see if this approach lowers the chance of the cancer coming back after surgery.
This trial tests a combination of an immunotherapy drug (tirelizumab) with two chemotherapy drugs before surgery for head and neck cancer that has spread to lymph nodes. The goal is to shrink the tumor and improve treatment outcomes.
This study uses ultrasound to monitor a small clip placed in a lymph node affected by breast cancer to see how well it responds to chemotherapy before surgery. It might help predict if the cancer is gone from the lymph nodes without needing extra surgery.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.